HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 3.425
+0.065 (1.93%)
Oct 9, 2026, 4:08 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.96 billion as of October 9, 2026. It is the 19,627th most valuable company in the world and the 879th biggest in Hong Kong. Its market cap has decreased by 8.18% in one year.
Market Cap
1.96B
Enterprise Value
1.77B
Revenue
n/a
Global Rank
Country Rank
#879 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.96B, a decrease of -69.29%. That is a compound annual growth rate of -34.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.96B | 16.10% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HJ Science | 2.59B |
| Clover Biopharmaceuticals | 2.32B |
| Frontage Holdings | 2.25B |
| AIM Vaccine | 2.20B |
| Antengene Corporation | 2.19B |
| Mabpharm | 2.08B |
| Shandong Boan Biotechnology | 1.93B |
| PegBio | 1.83B |